NYSEHLN

phototechno Consumer healthcare company Haleon (NYSE:HLN) announced an agreement on Wednesday to sell its nicotine replacement therapy (NRT) business outside the U.S. to a subsidiary of the Indian drugmaker Dr. Reddy’s Laboratories (NYSE:RDY). Per the terms, Dr. Reddy’s Laboratories SA, a unit of Dr. Reddy’s (RDY), will buy Haleon’s (HLN)Continue Reading